The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression

Annals of Surgical Oncology

Volumn 17, Issue 12, 2010, Pages 3354-3361

  Ye, Yanwei ^a,b   Shi, Yingqiang ^a,b   Zhou, Ye ^a,b   Du, Chunyan ^a,b   Wang, Chunmeng ^a,b   Zhan, Heqin ^a,b   Zheng, Biqiang ^a,b   Cao, Xi ^a,b   Sun, Meng Hong ^a,b   Fu, Hong ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; FIBROBLAST GROWTH FACTOR RECEPTOR 4; MESSENGER RNA;

ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CARCINOMA, SIGNET RING CELL; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 4; RNA, NEOPLASM; STOMACH NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 78650976905     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1323-6     Document Type: Article

References (23)

1. F Kamangar GM Dores WF Anderson 2006 Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137 2150 10.1200/JCO.2005.05.2308 16682732 (Pubitemid 46655601)
2. C Basilico D Moscatelli 1992 The FGF family of growth factors and oncogenes Adv Cancer Res 59 115 165 1:CAS:528:DyaK3sXntlOhuw%3D%3D 10.1016/S0065-230X(08)60305-X 1381547
3. M Ozen D Giri F Ropiquet, et al. 2001 Role of fibroblast growth factor receptor signaling in prostate cancer cell survival J Natl Cancer Inst (Bethesda) 93 1783 1790 1:CAS:528:DC%2BD38XhtlSjtQ%3D%3D
4. VP Eswarakumar I Lax J Schlessinger 2005 Cellular signaling by fibroblast growth factor receptors Cytokine Growth Factor Rev. 16 139 149 1:CAS:528:DC%2BD2MXjvVOns7k%3D 10.1016/j.cytogfr.2005.01.001 15863030 (Pubitemid 40616112)
5. J Wang DW Stockton M Ittmann 2004 The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression Clin Cancer Res 10 6169 6178 1:CAS:528:DC%2BD2cXnvVOjs7g%3D 10.1158/1078-0432. CCR-04-0408 15448004 (Pubitemid 39287523)
6. J Bange D Prechtl Y Cheburkin, et al. 2002 Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele Cancer Res 62 840 847 1:CAS:528:DC%2BD38Xht1Kru7k%3D 11830541
7. N Nakamura T Iijima K Mase, et al. 2004 Phenotypic differences of proliferating fibroblasts in the stroma of lung adenocarcinoma and normal bronchus tissue Cancer Sci. 95 226 232 1:CAS:528:DC%2BD2cXjs1ymurk%3D 10.1111/j.1349-7006.2004.tb02207.x 15016321 (Pubitemid 38489088)
8. M Kan X Wu F Wang, et al. 1999 Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase J Biol Chem. 274 15947 15952 1:CAS:528:DyaK1MXjsV2gur0%3D 10.1074/jbc.274.22.15947 10336501 (Pubitemid 29254976)
9. BC Lin M Wang C Blackmore, et al. 2007 Liver-specific activities of FGF19 require Klotho beta J Biol Chem. 282 27277 27284 1:CAS:528:DC%2BD2sXhtVWjsLfE 10.1074/jbc.M704244200 17627937 (Pubitemid 47501977)
10. HY Leung WJ Gullick NR Lemoine 1994 Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer Int J Cancer 59 667 675 1:CAS:528:DyaK2MXivFSmtrw%3D 10.1002/ijc.2910590515 7960240 (Pubitemid 24358591)
11. A Takahashi H Sasaki SJ Kim, et al. 1999 Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique Biochem Biophys Res Commun 257 855 859 1:CAS:528:DyaK1MXisVaitbk%3D 10.1006/bbrc.1999.0465 10208873 (Pubitemid 29301531)
12. C Thussbas J Nahrig S Streit, et al. 2006 FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer J Clin Oncol 24 3747 3755 1:CAS:528:DC%2BD28XpsVaqsrc%3D 10.1200/JCO.2005.04.8587 16822847 (Pubitemid 46622313)
13. M Spinola V Leoni C Pignatiello, et al. 2005 Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients J Clin Oncol 23 7307 7311 1:CAS:528:DC%2BD2MXhtF2nsLrM 10.1200/JCO.2005.17.350 16061909 (Pubitemid 46202344)
14. S Streit J Bange A Fichtner, et al. 2004 Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma Int J Cancer 111 213 217 1:CAS:528:DC%2BD2cXlvFWnsLg%3D 10.1002/ijc.20204 15197773 (Pubitemid 38924697)
15. Y Morimoto T Ozaki M Ouchida, et al. 2003 Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma Cancer. 98 2245 2250 1:CAS:528: DC%2BD3sXps1ars7g%3D 10.1002/cncr.11778 14601095 (Pubitemid 37392429)
16. Z Ma N Tsuchiya T Yuasa, et al. 2008 Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population Int J Cancer 123 2574 2579 1:CAS:528:DC%2BD1cXhtlyru7vF 10.1002/ijc.23578 18756523
17. FS Falvella E Frullanti A Galvan, et al. 2009 FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung Int J Cancer 124 2880 2885 1:CAS:528:DC%2BD1MXltlCgtbc%3D 10.1002/ijc.24302 19296538
18. J Tanuma T Izumo M Hirano, et al. 2010 FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma Oncol Rep 23 739 744 1:CAS:528:DC%2BC3cXjtlGrtrc%3D 20127014
19. A Matakidou R El Galta MF Rudd, et al. 2007 Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis Br J Cancer 96 1904 1907 1:CAS:528:DC%2BD2sXmtlyqurw%3D 10.1038/sj.bjc.6603816 17519899 (Pubitemid 46912027)
20. YC Yang ML Lu JY Rao, et al. 2006 Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis Br J Cancer 95 1455 1458 1:CAS:528:DC%2BD28Xht1Cntr3N 10.1038/sj.bjc.6603456 17088904 (Pubitemid 44863347)
21. CK Ho S Anwar J Nanda, et al. 2010 FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men Prostate Cancer Prostatic Dis. 13 94 96 1:CAS:528:DC%2BC3cXhslOht70%3D 10.1038/pcan.2009.49 19918264
22. R Naidu YC Har NA Taib 2009 Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development Oncol Res 18 65 71 1:CAS:528:DC%2BC3cXisVejsQ%3D%3D 10.3727/096504009789954609 20066896
23. HK Ho S Pok S Streit, et al. 2009 Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention J Hepatol 50 118 127 1:CAS:528:DC%2BD1cXhsVCkt77I 10.1016/j.jhep.2008.08.015 19008009